For additional perspective, heres a list of more studies that show the same: A potential link between liraglutide and thyroid cancer (along with pancreatic and gallbladder problems as well) (3) Study highlighting that liraglutide should not be used in people with a family history of medullary thyroid cancer (4) A study showing there is no increase in the risk of thyroid cancer (for additional perspective) (5) A meta-analysis showing that there is not enough evidence to suggest there is a link between thyroid cancer and GLP-1 agonists (6) Its worth pointing out that while there is still debate on this topic, the larger and bigger studies on this issue seem to support a connection between the two
During metabolic stress, the Sigma-1 receptor (S1R) plays a pivotal role in stabilizing IP3Rs at the contact site, preventing their degradation and maintaining the bioenergetic flow required for cellular survival (Hayashi and Su, 2007
Perfect for individuals seeking clean daily metabolic support
That interpretation of the rules is being challenged in the courts by Novo Nordisk and Eli Lilly, which makes rival weight-loss therapy tirzepatide, while the compounders have countersued, claiming that the FDA's removal of the drugs from the shortages list was premature
Diabetes, Obesity and Metabolism, 23(8), 18341842
[DOI] [PubMed] [Google Scholar] 110.Gerstein HC, et al
